Dear E,
Most biotech and life science organizations today have a common mission objective. Beyond ensuring patient access to medical treatments and providing shareholder value, these companies focus on two key areas— discovering emerging technologies, supporting early research, driving medical innovation, and ensuring clinical, regulatory, and commercial success of new products that address unmet medical needs.
Given the significant risks associated with the development of new therapeutics and the sizeable investment required upfront, many companies look to external sources of innovation and innovative partnerships to supplement organic pipeline growth and replace key products within their portfolios. It is essential for leadership from corporate strategy, business development, commercial, and R&D organizations are all aligned in their vision in order to map out the best long-term strategies that cater to the unique needs of their organization and ensure their success in years to come.
The 4th FierceBiotech Drug Development Forum, taking place on October 28–29 in Boston, provides a unique opportunity for attendees, highlighting C-suite and executive leadership perspectives on how to successfully discover, develop, and commercialize a product. Our speaking faculty will also address key business considerations, discussing how to map out the right financing strategy for your company and sharing strategies to mitigate risks and unlock the potential of acquisitions, licensing deals, and partnerships.
